Sickle cell anemia is rare in the general population but relatively common within specific ethnic groups. Globally, about 7.7 million people live with sickle cell disease, and in the United States, roughly 1 in every 2,000 newborns is diagnosed with it. Those numbers shift dramatically depending on ancestry: among Black newborns in the U.S., the rate is closer to 1 in 350.
How Common It Is in the United States
Sickle cell disease affects an estimated 100,000 people in the United States, making it one of the more common inherited blood disorders in the country. That figure represents less than 0.03% of the total U.S. population, which qualifies it as a rare disease by federal standards (any condition affecting fewer than 200,000 Americans).
The overall birth prevalence is about 1 in every 2,070 live births based on data from 11 states collected between 2016 and 2020. But the disease doesn’t affect all groups equally. Among non-Hispanic Black newborns, the rate is 1 in 350. Among Hispanic American newborns, it drops to roughly 1 in 16,300. More than 90% of people living with sickle cell disease in the U.S. are Black or African American, and an estimated 3% to 9% are Hispanic or Latino.
The Global Picture
Worldwide, sickle cell disease is far from rare. An estimated 7.74 million people were living with it in 2021, a 41% increase from 5.46 million in 2000. That growth is driven largely by population increases in regions where the disease is most concentrated, particularly sub-Saharan Africa, which accounts for roughly 80% of all cases globally.
In sub-Saharan Africa, the mortality toll is severe. Among children under five with sickle cell disease, death rates range from 50% to 80% in areas with limited access to newborn screening and treatment. Globally, the total mortality burden reached an estimated 376,000 deaths in 2021.
India carries the next-largest burden. About 1.17% of the Indian population has sickle cell disease, with higher rates concentrated in tribal communities and the central states of Madhya Pradesh, Chhattisgarh, and Maharashtra. Nearly 6% of India’s population carries the sickle cell trait without having the disease itself. The condition also appears at elevated rates in parts of the Mediterranean, the Middle East, and Central America.
Carriers vs. People With the Disease
There’s a big difference between carrying one copy of the sickle cell gene and having the disease. An estimated 300 million people worldwide, roughly 5% of the global population, carry a single copy. These carriers have what’s called sickle cell trait. They typically don’t experience the painful crises and organ damage that define sickle cell disease, though the trait is not entirely harmless and can cause complications in extreme conditions like severe dehydration or high altitude.
To develop sickle cell disease, a child must inherit the altered gene from both parents. When two carriers have a child together, there’s a 25% chance that child will have the disease, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither copy. This inheritance pattern is why the disease clusters so strongly in populations where the trait is common. In those regions, the trait historically offered a survival advantage by providing some protection against malaria, which kept it circulating at high rates over generations.
Why It Concentrates in Certain Populations
The geographic and ethnic patterns of sickle cell disease trace back thousands of years to regions where malaria was endemic. People carrying one copy of the sickle gene were more likely to survive malaria outbreaks and pass on their genes. Over centuries, this made the trait common across equatorial Africa, the Indian subcontinent, the Arabian Peninsula, and parts of southern Europe.
In the United States, the concentration among Black Americans reflects this ancestral connection to sub-Saharan Africa. The disease also appears in Hispanic communities, particularly those with Caribbean or Central American ancestry, and occasionally in people of Mediterranean, Middle Eastern, or South Asian descent. If you’re outside these groups, encountering sickle cell disease is genuinely rare.
Rare Disease, Large Impact
Whether sickle cell anemia counts as “rare” depends on your frame of reference. In the U.S. and Europe, it meets the formal definition of a rare disease, and many people will never encounter it. Globally, nearly 8 million people live with it, and roughly 5.5 million babies are born each year carrying at least one copy of the gene. Within Black American communities, it’s common enough that most families have some personal experience with the trait or the disease.
Every U.S. state now screens newborns for sickle cell disease at birth, regardless of ethnicity. Early detection has transformed outcomes in high-income countries, where most children with the disease now survive into adulthood. In sub-Saharan Africa, where screening and treatment infrastructure remain limited, the disease still kills hundreds of thousands of people each year, most of them young children.